Aptus Pharma plans ₹44.88 crore raise for manufacturing and global expansion
Aptus Pharma proposes a preferential equity issue to fund manufacturing and storage capacity, working capital and distribution expansion. The company targets 20% in-house production and export growth across Africa, the Middle East and Latin America, subject to shareholder approval.
What happened
Aptus Pharma plans to raise Rs 44.88 crore to build manufacturing and storage capacity, expand working capital and strengthen its balance sheet. It targets 20%
Key facts
- Rs 44.88 crore preferential issue
- Rs 25 crore for capital expenditure
- Rs 10 crore for working capital
- Rs 9.88 crore for general corporate purposes
- 20% of product requirements targeted through in-house manufacturing
- 1.99% stock rise
- Rs 296.40 BSE intraday high
- 36 months proposed fund utilisation
Why this matters
Aptus is building capabilities for broader Africa, Middle East and Latin America distribution, potentially creating partnership, licensing and supply-chain opportunities as its internal manufacturing footprint expands.
What to watch
- Shareholder vote outcome and timeline for preferential allotment.
- Final equity issue terms, including pricing, warrant structure, promoter participation and resulting dilution.
- Capex commissioning milestones and evidence of incremental manufacturing/storage capacity.
- In-house production share progressing toward 20%.
- Gross-margin movement versus outsourced production costs.
- Inventory days, receivable days and operating-cash-flow performance as distribution expands.
- New export registrations, distributor agreements and geography-specific revenue disclosures.
- Regulatory, currency, freight and payment-collection risks in export markets.
- Seek shareholder approval for the preferential equity issue and disclose issue price, investor participation and dilution details.
- Complete fundraise and allocate approximately ₹25 crore toward manufacturing and storage infrastructure.
- Raise in-house production toward the stated 20% target, reducing external manufacturing dependence.
- Expand working-capital support for inventory, receivables and distributor stocking.
- Pursue export registrations, local distribution partnerships and order wins across Africa, the Middle East and Latin America.